Center Jean Perrin

Clermont-Ferrand 63011

0 studies enrolling now · 2 studies all time

What they study most

HER2+ Metastatic Breast Cancer (MBC), Prostate Cancer

Studies at this site

• Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer — Completed
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed